DIAGENS-B (02526) has announced that its board of directors passed a resolution during a meeting held on April 29, 2026, recommending the adoption of a share incentive plan. The plan aims to foster the company's long-term sustainable development, attract and retain qualified participants who contribute to the group's sustained growth and success, align the interests of incentive recipients, shareholders, and the company, and optimize the corporate incentive structure. Grants of restricted share units and share options will be funded through the following methods: H shares purchased by a trustee on the secondary market; new H shares to be issued by the company; and treasury shares legally held by the company, if any.